| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 57.9933 | 63 |
| GSM780708 | Untreated after 4 days (C2_1) | 43.1244 | 18 |
| GSM780709 | Untreated after 4 days (C3_1) | 48.9886 | 45 |
| GSM780719 | Untreated after 4 days (C1_2) | 48.2769 | 42 |
| GSM780720 | Untreated after 4 days (C2_2) | 56.0268 | 61 |
| GSM780721 | Untreated after 4 days (C3_2) | 51.6879 | 53 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 53.3024 | 57 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 51.4059 | 52 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 52.7853 | 56 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 53.5465 | 57 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 53.2071 | 57 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 62.033 | 66 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 50.077 | 49 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 47.4808 | 39 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 50.7461 | 51 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 53.1329 | 56 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 52.8235 | 56 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 53.2724 | 57 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 54.9354 | 59 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 53.0207 | 56 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 48.8106 | 44 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 59.4268 | 64 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 48.4524 | 43 |